Umang M Barvalia
Pulmonary Disease · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 23
- 4 carriers
- Office
- 1
Offices
1 location · County of Santa Clara · 1,000 clinicians in this group
Hospitals listed: Santa Clara Valley Medical Center. That is not proof they admit you there this week.
Plans that list them
23 plans · 4 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Umang M Barvalia’s office at (408) 885-5000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
23 of 23 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Original Medicare doctor bills
$54,596
Medicare paid this office $54,596 for 244 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Critical care, first 30-74 minutes | 64 | $30,906 | $184 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 47 | $7,033 | $107 |
| Short return visit (20+ min) | 68 | $4,030 | $51 |
| Return visit (30+ min) | 31 | $2,645 | $83 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 23 | $2,491 | $108 |
See all 10 services
| Critical care, first 30-74 minutes | 64 | $30,906 | $184 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 47 | $7,033 | $107 |
| Short return visit (20+ min) | 68 | $4,030 | $51 |
| Return visit (30+ min) | 31 | $2,645 | $83 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 23 | $2,491 | $108 |
| New patient visit (45+ min) | 17 | $1,668 | $98 |
| Test to determine lung volumes using sensors | 42 | $373 | $9 |
| Test to examine how well the lungs exchange gases | 42 | $276 | $7 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 23 | $171 | $7 |
| Test to measure expiratory airflow and volume | 23 | $146 | $6 |
Who their Medicare patients are
244 Original Medicare patients in 2024. Average age 73 · Under 65 13% · 85 and older 14% · Women 48% · Also on Medicaid 84% · Health risk score 3.12. Above the middle of the specialty; the typical pulmonary disease clinician is at 2.13.
Conditions among them: High blood pressure 75% · Diabetes 49% · COPD 48% · Heart failure 44% · Coronary heart disease 36% · Chronic kidney disease 36% · Atrial fibrillation 28% · Depression 25% · Stroke 19% · Cancer 18% · Dementia 18%.
The office billed $588,332, Medicare allowed $71,221 and paid $54,596; for 580 services of 35 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 244 | 580 | 73 | 3.12 | $588,332 | $54,596 |
| 2023 | 220 | 484 | 71 | 2.64 | $541,334 | $54,643 |
| 2022 | 204 | 434 | 72 | 2.31 | $427,730 | $49,401 |
| 2021 | 181 | 405 | 70 | 2.49 | $465,528 | $55,675 |
| 2020 | 196 | 424 | 70 | 2.75 | $428,116 | $53,844 |
| 2019 | 260 | 542 | 69 | 2.59 | $476,568 | $50,291 |
| 2018 | 76 | 131 | 69 | 2.24 | $135,463 | $15,321 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 9 services
| Critical care, first 30-74 minutes | 67 | $34,036 | $197 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 55 | $7,964 | $115 |
| Short return visit (20+ min) | 46 | $2,562 | $52 |
| Return visit (30+ min) | 32 | $2,490 | $71 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 17 | $2,242 | $125 |
| Test to determine lung volumes using sensors | 22 | $208 | $9 |
| Test to examine how well the lungs exchange gases | 22 | $154 | $7 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 16 | $130 | $8 |
| Test to measure expiratory airflow and volume | 16 | $97 | $6 |
2022: 9 services
| Critical care, first 30-74 minutes | 54 | $26,301 | $219 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 44 | $7,677 | $113 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 22 | $3,340 | $139 |
| Short return visit (20+ min) | 46 | $2,625 | $52 |
| Return visit (30+ min) | 26 | $2,355 | $91 |
| Telephone medical discussion with physician, 21-30 minutes | 21 | $1,557 | $74 |
| Test to determine lung volumes using sensors | 20 | $211 | $11 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 16 | $152 | $9 |
| Test to examine how well the lungs exchange gases | 19 | $147 | $8 |
2021: 8 services
| Critical care, first 30-74 minutes | 60 | $38,692 | $222 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 31 | $3,794 | $108 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 22 | $3,127 | $142 |
| Short return visit (20+ min) | 28 | $1,806 | $60 |
| Return visit (30+ min) | 17 | $1,654 | $92 |
| Telephone medical discussion with physician, 5-10 minutes | 12 | $377 | $31 |
| Test to determine lung volumes using sensors | 14 | $147 | $10 |
| Test to examine how well the lungs exchange gases | 13 | $100 | $8 |
2020: 10 services
| Critical care, first 30-74 minutes | 54 | $36,589 | $233 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 30 | $4,492 | $107 |
| Telephone medical discussion with physician, 21-30 minutes | 38 | $2,891 | $72 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 16 | $2,198 | $137 |
| Short return visit (20+ min) | 39 | $1,750 | $38 |
| Return visit (30+ min) | 11 | $900 | $75 |
| Telephone medical discussion with physician, 11-20 minutes | 11 | $571 | $48 |
| Test to determine lung volumes using sensors | 14 | $93 | $7 |
| Test to examine how well the lungs exchange gases | 15 | $77 | $5 |
| Test to measure expiratory airflow and volume | 12 | $47 | $4 |
2019: 9 services
| Critical care, first 30-74 minutes | 68 | $31,523 | $193 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 37 | $5,020 | $93 |
| Short return visit (20+ min) | 96 | $4,247 | $40 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 21 | $2,439 | $116 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 13 | $1,236 | $65 |
| Test to determine lung volumes using sensors | 35 | $322 | $9 |
| Test to examine how well the lungs exchange gases | 34 | $230 | $7 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 22 | $213 | $10 |
| Test to measure expiratory airflow and volume | 17 | $114 | $7 |
2018: 2 services
| Critical care, first 30-74 minutes | 19 | $10,387 | $196 |
| Short return visit (20+ min) | 27 | $1,244 | $46 |
Medicaid work
$3,858 in 2024
Medicaid paid $3,858 for 1,187 billed services this clinician did in 2024, up to 38 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Short return visit (20+ min) | 150 | $1,047 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 91 | $1,026 |
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 53 | $947 |
| Plethysmography for determination of lung volumes and, when performed, airway resistance | 129 | $299 |
| Diffusing capacity | 130 | $203 |
| Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation | 74 | $152 |
| Return visit (30+ min) | 26 | $128 |
| EVALUATION OF WHEEZING | 28 | $57 |
| Pain severity quantified; no pain present (COA) (ONC) | 12 | $0 |
| Medication list documented in medical record (COA) | 161 | $0 |
| Review of all medications by a prescribing practitioner or clinical pharmacist (such as, prescriptions, OTCs, herbal therapies and supplements) documented in the medical record (COA) | 81 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 77 | $0 |
| 2024 | 1,187 | 15 | 38 | $3,858 |
| 2023 | 655 | 7 | 28 | $9,008 |
| 2022 | 322 | 5 | 22 | $1,805 |
| 2021 | 316 | 5 | 21 | $7,539 |
| 2020 | 340 | 7 | 22 | $10,288 |
| 2019 | 494 | 6 | 26 | $5,201 |
| 2018 | 123 | 2 | 27 | $2,964 |
See the largest Medicaid services in earlier years
2023
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 239 | $7,449 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 62 | $923 |
| Short return visit (20+ min) | 84 | $270 |
| Plethysmography for determination of lung volumes and, when performed, airway resistance | 90 | $146 |
| Diffusing capacity | 86 | $98 |
| Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation | 69 | $81 |
| EVALUATION OF WHEEZING | 25 | $41 |
2022
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 24 | $942 |
| Short return visit (20+ min) | 120 | $628 |
| Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation | 59 | $103 |
| Plethysmography for determination of lung volumes and, when performed, airway resistance | 60 | $80 |
| Diffusing capacity | 59 | $53 |
2021
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 192 | $7,282 |
| Short return visit (20+ min) | 54 | $153 |
| Plethysmography for determination of lung volumes and, when performed, airway resistance | 32 | $62 |
| Diffusing capacity | 21 | $27 |
| Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation | 17 | $16 |
2020
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 137 | $9,251 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 23 | $422 |
| Plethysmography for determination of lung volumes and, when performed, airway resistance | 52 | $180 |
| Short return visit (20+ min) | 33 | $147 |
| Diffusing capacity | 51 | $121 |
| Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation | 32 | $89 |
| EVALUATION OF WHEEZING | 12 | $78 |
2019
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 114 | $3,980 |
| Short return visit (20+ min) | 181 | $682 |
| Plethysmography for determination of lung volumes and, when performed, airway resistance | 72 | $237 |
| Diffusing capacity | 68 | $152 |
| Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation | 46 | $94 |
| EVALUATION OF WHEEZING | 13 | $56 |
2018
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 68 | $2,899 |
| Short return visit (20+ min) | 55 | $65 |
Drugs they prescribed that Part D paid
$516,239
Pharmacies billed $516,239 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 647) in 2024. At or below the middle of the specialty; the typical pulmonary disease clinician is at 0%.
238 generic and 409 brand-name prescriptions · $516,239 in drug cost · 28 antibiotic prescriptions to 15 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ofev | 12 | $161,615 | $13,468 |
| Nucala | 30 | $99,685 | $3,323 |
| Ambrisentan | 11 | $67,448 | $6,132 |
| Dupixent | 13 | $43,121 | $3,317 |
| Spiriva Handihaler | 30 | $18,595 | $620 |
See all 23 drugs
| Ofev | 12 | $161,615 | $13,468 |
| Nucala | 30 | $99,685 | $3,323 |
| Ambrisentan | 11 | $67,448 | $6,132 |
| Dupixent | 13 | $43,121 | $3,317 |
| Spiriva Handihaler | 30 | $18,595 | $620 |
| Spiriva Respimat | 29 | $15,519 | $535 |
| Incruse Ellipta | 23 | $11,567 | $503 |
| Budesonide-Formoterol | 54 | $10,480 | $194 |
| Breo Ellipta | 20 | $10,033 | $502 |
| Dulera | 24 | $7,614 | $317 |
| Advair Hfa | 17 | $7,254 | $427 |
| Atrovent Hfa | 17 | $7,229 | $425 |
| Wixela Inhub | 39 | $4,557 | $117 |
| Breyna | 20 | $3,581 | $179 |
| Advair Diskus | 13 | $3,299 | $254 |
| Albuterol Sulfate Hfa | 76 | $2,729 | $36 |
| Symbicort | 12 | $2,702 | $225 |
| Sildenafil Citrate | 25 | $680 | $27 |
| Ventolin Hfa | 11 | $678 | $62 |
| Azithromycin | 22 | $250 | $11 |
| Fluticasone Propionate | 21 | $104 | $5 |
| Montelukast | 13 | $85 | $7 |
| Prednisone | 23 | $50 | $2 |
Year by year
| 2024 | 647 | 130 | 0% (0) | 63% | $516,239 |
| 2023 | 510 | 99 | 0% (0) | 75% | $434,518 |
| 2022 | 441 | 98 | None | 73% | $244,646 |
| 2021 | 474 | 94 | None | 77% | $278,254 |
| 2020 | 495 | 97 | 0% (0) | 72% | $283,981 |
| 2019 | 297 | 90 | 0% (0) | 58% | $61,811 |
| 2018 | 73 | 27 | 0% (0) | 59% | $14,595 |
| 2016 | 16 | None | 0% (0) | None | $4,947 |
| 2015 | 311 | 39 | None | None | $34,656 |
| 2014 | 322 | 42 | 4% (13) | None | $12,151 |
| 2013 | 338 | 57 | None | None | $11,384 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 11 drugs
| Nucala | 34 | $132,755 | $3,905 |
| Advair Diskus | 73 | $47,392 | $649 |
| Symbicort | 45 | $21,111 | $469 |
| Spiriva Handihaler | 28 | $16,751 | $598 |
| Incruse Ellipta | 18 | $14,439 | $802 |
| Atrovent Hfa | 24 | $10,693 | $446 |
| Flovent Hfa | 15 | $3,394 | $226 |
| Ventolin Hfa | 43 | $3,025 | $70 |
| Albuterol Sulfate Hfa | 50 | $2,336 | $47 |
| Fluticasone Propionate | 19 | $296 | $16 |
| Prednisone | 18 | $132 | $7 |
2022: 12 drugs
| Nucala | 23 | $79,141 | $3,441 |
| Advair Diskus | 57 | $34,866 | $612 |
| Symbicort | 26 | $9,384 | $361 |
| Incruse Ellipta | 20 | $9,147 | $457 |
| Spiriva Handihaler | 16 | $8,288 | $518 |
| Spiriva Respimat | 13 | $5,371 | $413 |
| Atrovent Hfa | 13 | $5,358 | $412 |
| Flovent Hfa | 19 | $5,058 | $266 |
| Albuterol Sulfate Hfa | 63 | $3,718 | $59 |
| Ventolin Hfa | 25 | $1,561 | $62 |
| Montelukast | 16 | $289 | $18 |
| Prednisone | 21 | $193 | $9 |
2021: 14 drugs
| Esbriet | 13 | $82,587 | $6,353 |
| Nucala | 14 | $41,354 | $2,954 |
| Symbicort | 59 | $22,918 | $388 |
| Advair Diskus | 44 | $22,167 | $504 |
| Spiriva | 20 | $13,394 | $670 |
| Atrovent Hfa | 26 | $11,743 | $452 |
| Flovent Hfa | 31 | $9,868 | $318 |
| Incruse Ellipta | 22 | $8,219 | $374 |
| Breo Ellipta | 14 | $5,641 | $403 |
| Ventolin Hfa | 27 | $1,761 | $65 |
| Albuterol Sulfate Hfa | 30 | $1,601 | $53 |
| Sodium Chloride | 11 | $153 | $14 |
| Prednisone | 13 | $95 | $7 |
| Amlodipine Besylate | 17 | $48 | $3 |
2020: 16 drugs
| Symbicort | 68 | $23,187 | $341 |
| Advair Diskus | 35 | $20,444 | $584 |
| Spiriva | 33 | $16,866 | $511 |
| Atrovent Hfa | 19 | $12,541 | $660 |
| Incruse Ellipta | 17 | $7,124 | $419 |
| Trelegy Ellipta | 12 | $7,121 | $593 |
| Combivent Respimat | 11 | $4,858 | $442 |
| Breo Ellipta | 11 | $4,593 | $418 |
| Flovent Hfa | 11 | $4,267 | $388 |
| Ventolin Hfa | 57 | $3,479 | $61 |
| Wixela Inhub | 11 | $3,377 | $307 |
| Albuterol Sulfate Hfa | 33 | $1,798 | $54 |
| Fluticasone Propionate | 18 | $147 | $8 |
| Prednisone | 22 | $139 | $6 |
| Montelukast | 11 | $64 | $6 |
| Amlodipine Besylate | 11 | $28 | $3 |
2019: 6 drugs
| Symbicort | 49 | $16,330 | $333 |
| Incruse Ellipta | 15 | $5,841 | $389 |
| Atrovent Hfa | 11 | $4,268 | $388 |
| Ventolin Hfa | 33 | $2,149 | $65 |
| Fluticasone Propionate | 20 | $191 | $10 |
| Prednisone | 18 | $115 | $6 |
2015: 7 drugs
| Levemir Flextouch | 18 | $7,101 | $394 |
| Proair Hfa | 14 | $1,477 | $106 |
| Pravastatin | 16 | $263 | $16 |
| Metformin | 16 | $165 | $10 |
| Lisinopril | 12 | $88 | $7 |
| Simvastatin | 14 | $73 | $5 |
| Glipizide | 11 | $53 | $5 |
2014: 11 drugs
| Pravastatin | 14 | $443 | $32 |
| Clopidogrel | 13 | $255 | $20 |
| Lisinopril | 22 | $174 | $8 |
| Fluoxetine | 17 | $160 | $9 |
| Levothyroxine | 12 | $155 | $13 |
| Simvastatin | 23 | $151 | $7 |
| Metoprolol | 17 | $125 | $7 |
| Omeprazole | 16 | $120 | $8 |
| Tramadol | 12 | $119 | $10 |
| Allopurinol | 13 | $101 | $8 |
| Lisinopril-Hydrochlorothiazide | 14 | $93 | $7 |
2013: 7 drugs
| Metoprolol | 32 | $319 | $10 |
| Isosorbide Mononitrate Er | 11 | $177 | $16 |
| Simvastatin | 19 | $174 | $9 |
| Levothyroxine | 13 | $168 | $13 |
| Oxybutynin Chloride | 12 | $145 | $12 |
| Omeprazole | 12 | $138 | $11 |
| Lisinopril | 15 | $94 | $6 |
Money from drug and device companies
$22 in 2025
| 2025 | 1 | 1 | None | $22 |
| 2024 | 2 | 2 | None | $40 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Actelion Pharmaceuticals US | Uptravi | $22 | 1 payment
|
See the published payment
| Actelion Pharmaceuticals US | Meals · 2025-05-07 | Uptravi | $22 |
See earlier years (2024)
2024: $40
| Actelion Pharmaceuticals US | Uptravi | $23 | 1 payment
|
| Insmed | Arikayce | $16 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 80.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1578827242
- Licence
- WI 61411-20
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 207RP1001X (207RP1001X); Student in a training program (390200000X)
- Mailing address
- 600 Highland Ave, Madison, WI, 53792
- NPI first listed
- 2012-06-27
- NPI last updated
- 2017-01-06
This is when the NPI record was last certified, not a medical board exam.